Topics

TOPICS

ANEMIA

Parsaclisib May Be Safe, Effective in Autoimmune Hemolytic Anemia

Eculizumab Biosimilar Appears Effective in Paroxysmal Nocturnal Hemoglobinuria

BLEEDING DISORDERS

Use of a Smart Medical Internet of Things System on Quality of Life in Patients With Hemophilia

Long-Term Prophylaxis Cost-Effective for Von Willebrand Disease

GENERAL HEMATOLOGY

Combining Ruxolitinib With Donor Regulatory T Cells May Outperform Monotherapy in Chronic Graft Vs Host Disease

Discordance in Symptomatic Adverse Event Reports by Clinicians, Children in Cancer Clinical Trials

LEUKEMIA

Bax/Bcl-2 Expression in Pediatric Acute Lymphoblastic Leukemia

Combo Produces High Response Rate in Older Adults With Ph-Negative B-ALL

LYMPHOMA

Long-Term Efficacy of Zanubrutinib Confirmed for Mantle Cell Lymphoma

Response to Axicabtagene Ciloleucel Superior to Standard Care in R/R Large B-Cell Lymphoma

MYELODYSPLASTIC SYNDROMES

TP53 Mutations Predict Poor Outcomes in Patients With MDS or AML With Complex Karyotype

Pretreatment Peripheral Blood Inflammatory Indices May Have Prognostic Value in Myelodysplastic Syndrome

MYELOMA

Antithrombotic Treatment Resistance in Multiple Myeloma Likely Multifactorial

Triplet Maintenance After HSCT Improves PFS vs Lenalidomide Alone in Multiple Myeloma

SIDE EFFECT MANAGEMENT

ONS Releases Guidelines on the Management of Cancer Treatment–Related Hot Flashes

New NCCN Patient Guidelines Feature Immunotherapy, CAR-T Side Effects

THALASSEMIAS

Beti-Cel, a Gene Therapy for Beta-Thalassemia, Gets FDA Panel Support

Bristol Myers Squibb Withdraws Luspatercept sBLA for NTD Beta Thalassemia

THROMBOTIC DISORDERS

Anticoagulation in Non-ICU Patients With COVID-19 at High Thrombosis Risk

Thromboembolic Events Among Patients Hospitalized With COVID-19 Pneumonia

Next post in General Hematology

pediatric-thyroid-cancer-rising

Discordance in Symptomatic Adverse Event Reports by Clinicians, Children in Cancer Clinical Trials